Penumbra, Inc. Common Stock (PEN) stock analysis

PEN · Penumbra, Inc. Common Stock

Latest recorded price: USD 320.62

Model-estimated fair value: USD 38.90. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Medical Devices

At $320.62, PEN trades 724.1% above the model's base-case value of $38.90. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $33.38 in the conservative case and $45.69 in the optimistic case, with a valuation confidence score of 55/100. About 76% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 18.3%, free cash flow margin 12.5%, ROIC 19.8%. The model does not flag any risk signals for this company.

Similar companies in Healthcare